146 related articles for article (PubMed ID: 17305021)
21. Clinical sabbatical aims to beef up trial-management skills.
Palmer R
Nat Med; 2010 Nov; 16(11):1170. PubMed ID: 21052052
[No Abstract] [Full Text] [Related]
22. Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials.
Lantos JD; Wendler D; Septimus E; Wahba S; Madigan R; Bliss G
Clin Trials; 2015 Oct; 12(5):485-93. PubMed ID: 26374686
[TBL] [Abstract][Full Text] [Related]
23. [Effects of the 12th amendment to the German drug code on investigator-initiated clinical trials].
Kehrel U
Gesundheitswesen; 2011 Oct; 73(10):696-701. PubMed ID: 20859850
[TBL] [Abstract][Full Text] [Related]
24. Guidance on financial disclosure requirements.
Maloney DM
Hum Res Rep; 2001 May; 16(5):4. PubMed ID: 11833562
[No Abstract] [Full Text] [Related]
25. The role of cooperative groups in cancer clinical trials.
Mauer AM; Rich ES; Schilsky RL
Cancer Treat Res; 2007; 132():111-29. PubMed ID: 17305018
[No Abstract] [Full Text] [Related]
26. Compensation guidelines for research-related injury in India could destroy investigator-initiated research.
Pramesh CS; Badwe RA
Natl Med J India; 2012; 25(1):35-7. PubMed ID: 22680323
[No Abstract] [Full Text] [Related]
27. The value of research collaborations and consortia in rare cancers.
Blay JY; Coindre JM; Ducimetière F; Ray-Coquard I
Lancet Oncol; 2016 Feb; 17(2):e62-e69. PubMed ID: 26868355
[TBL] [Abstract][Full Text] [Related]
28. Cancer clinical trials, UK research networks and the shape of things to come.
Selby P
Clin Oncol (R Coll Radiol); 2004 Oct; 16(7):443-4. PubMed ID: 15490802
[No Abstract] [Full Text] [Related]
29. Paving the road to clinical trial participation: removing road blocks and directing patients toward novel therapies.
Wang-Gillam A; Williams K
J Natl Compr Canc Netw; 2015 Jan; 13(1):118-20. PubMed ID: 25583774
[No Abstract] [Full Text] [Related]
30. So You Want to Be a Principal Investigator.
Saleh M; Naik G
J Oncol Pract; 2018 Jun; 14(6):e384-e392. PubMed ID: 29750578
[TBL] [Abstract][Full Text] [Related]
31. Cooperative Group Trials in the Community Setting.
Lloyd Wade J; Petrelli NJ; McCaskill-Stevens W
Semin Oncol; 2015 Oct; 42(5):686-92. PubMed ID: 26433550
[TBL] [Abstract][Full Text] [Related]
32. US Cancer Moonshot must strike a balance between research and prevention.
Nature; 2016 Nov; 539(7630):467. PubMed ID: 27882989
[No Abstract] [Full Text] [Related]
33. Open letter on access to the BIA 10-2474 clinical trial data.
Brøsen K; Funck-Brentano C; Kroemer HK; Pirmohamed M; Schwab M
Lancet; 2017 Jan; 389(10065):156. PubMed ID: 27955829
[No Abstract] [Full Text] [Related]
34. Exploring the ethical and regulatory issues in pragmatic clinical trials.
Califf RM; Sugarman J
Clin Trials; 2015 Oct; 12(5):436-41. PubMed ID: 26374676
[TBL] [Abstract][Full Text] [Related]
35. The impact of registration of clinical trials units: the UK experience.
McFadden E; Bashir S; Canham S; Darbyshire J; Davidson P; Day S; Emery S; Pater J; Rudkin S; Stead M; Brown J
Clin Trials; 2015 Apr; 12(2):166-73. PubMed ID: 25475881
[TBL] [Abstract][Full Text] [Related]
36. [Impact of Spanish Law 14/2007 of biomedical research on clinical trials].
Ramiro Avilés MA
Med Clin (Barc); 2008 May; 130(20):783-6. PubMed ID: 18579033
[No Abstract] [Full Text] [Related]
37. Today's Russian clinical trial environment.
Virk KP
Int J Clin Pract; 2010 Sep; 64(10):1347-9. PubMed ID: 20716142
[No Abstract] [Full Text] [Related]
38. Health research oversight in Africa.
Noor RA
Acta Trop; 2009 Nov; 112 Suppl 1():S63-70. PubMed ID: 19698692
[TBL] [Abstract][Full Text] [Related]
39. Innovating openly: researchers and patients turn to crowdsourcing to collaborate on clinical trials, drug discovery, and more.
Morton CC
IEEE Pulse; 2014; 5(1):63-7. PubMed ID: 25296376
[No Abstract] [Full Text] [Related]
40. Medicinal studies in palliative care: impact of the EU clinical trials directive.
Spathis A
Palliat Med; 2007 Jan; 21(1):60-1. PubMed ID: 17169963
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
